Compare PRCT & BTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRCT | BTZ |
|---|---|---|
| Founded | 2009 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 998.6M |
| IPO Year | 2021 | N/A |
| Metric | PRCT | BTZ |
|---|---|---|
| Price | $21.35 | $9.98 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $35.44 | N/A |
| AVG Volume (30 Days) | ★ 966.6K | 292.6K |
| Earning Date | 04-29-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.40% |
| EPS Growth | ★ 1.71 | N/A |
| EPS | N/A | ★ 1.41 |
| Revenue | ★ $308,054,000.00 | N/A |
| Revenue This Year | $31.34 | N/A |
| Revenue Next Year | $24.52 | N/A |
| P/E Ratio | ★ N/A | $7.06 |
| Revenue Growth | ★ 37.22 | N/A |
| 52 Week Low | $16.67 | $9.70 |
| 52 Week High | $40.10 | $11.18 |
| Indicator | PRCT | BTZ |
|---|---|---|
| Relative Strength Index (RSI) | 51.15 | 38.50 |
| Support Level | $21.28 | $9.89 |
| Resistance Level | $29.27 | $10.22 |
| Average True Range (ATR) | 1.05 | 0.08 |
| MACD | 0.04 | -0.03 |
| Stochastic Oscillator | 38.32 | 7.14 |
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
Blackrock Credit Allocation Income Trust is a diversified, closed-end Trust engaged in providing investment advisory and risk management solutions. Its investment objective is to seek current income, current gains, and capital appreciation. The company invests under normal market conditions, at least 80% of its assets in credit-related securities, including, but not limited to, investment-grade corporate bonds, high-yields, bank loans, preferred securities or convertible bonds, or derivatives with economic characteristics similar to these credit-related securities.